Skip to content
TdC 122: Esteatose Hepática episode artwork

Jan 20, 2022 51 min

TdC 122: Esteatose Hepática

from Ta de Clinicagem Hosted by tadeclinicagem

🎁 Os melhores descontos do ano! Clique no link e confira as promoções de BLACKFRIDAY do TdC! 🔸 Guia TdC + questões com desconto no plano anual! 🔸 Curso de gasometria 40%OFF 🔸 Curso de antibióticos 40% OFF 🔸 Curso de atualização em clínica médica 40% OFF 🔸 Curso de intubação 40% OFF Compre pelo link: https://www.tadeclinicagem.com.br/blackfriday/ 🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨 Joanne, Marcela e Fred discutem sobre doença hepática gordurosa não alcoólica. Comentam sobre a confusão das nomenclaturas (NASH? NAFLD? Esteatose?), sobre os diagnósticos diferenciais, sobre os exames auxiliares (biópsia, elastografia) e sobre o tratamento. Referências 1. Chalassani N, et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. HEPATOLOGY, VOL. 67, NO. 1, 2018 2. Diehl AM, Day C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. N Engl J Med. 2017. 377;21 3. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease, Journal of Hepatology, Volume 64, Issue 6, 2016, Pages 1388-1402. 4. Glen J, Floros L, Day C, Pryke R. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance BMJ 2016; 354 :i4428. 5. Roeb E. Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. 2021. Visc Med. 6. Pandyarajan, Vijay et al. “Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic.” Gastroenterology & hepatology vol. 15,7 (2019): 357-365. 7. Sheka AC, et al. Nonalcoholic Steatohepatitis. A Review. JAMA. 2020. vol 323 N 12. 8. Sheth SG, et al. Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults. UpToDate. Acesso em Jan/2022. 9. Vuppalanchi, R., Gould, R.J., Wilson, L.A. et al. Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. Hepatol Int 6, 379–385 (2012). 10. Hernaez, Ruben, et al. "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis." Hepatology 54.3 (2011): 1082-1090. 11. de Moura Almeida, Alessandro, et al. "Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound." World journal of gastroenterology: WJG 14.9 (2008): 1415. 12. Mottin, Cláudio C., et al. "The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients." Obesity surgery 14.5 (2004): 635-637. 13. Cho C.S., et al. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg. 2008 Mar;206(3):480-8. 14. Crossan, Catriona, et al. "Referral pathways for patients with NAFLD based on non‐invasive fibrosis tests: Diagnostic accuracy and cost analysis." Liver International 39.11 (2019): 2052-2060. 15. Boursier, Jerome, and Emmanuel A. Tsochatzis. "Case-finding strategies in non-alcoholic fatty liver disease." JHEP Reports 3.2 (2021): 100219. 16. Shah, Amy G., et al. "Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease." Clinical gastroenterology and hepatology 7.10 (2009): 1104-1112.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

TdC 122: Esteatose Hepática

0:00 51:52

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Ta de Clinicagem?

This episode is 51 minutes long.

When was this Ta de Clinicagem episode published?

This episode was published on January 20, 2022.

Can I download this Ta de Clinicagem episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.